BXRX

Baudax Bio, Inc. Common Stock

Delisted

BXRX was delisted on the 15th of November, 2023.

19 hedge funds and large institutions have $1.08M invested in Baudax Bio, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$165K
2 +$70.2K
3 +$24K
4
HF
HRT Financial
New York
+$19K
5
VF
Virtu Financial
New York
+$17K

Top Sellers

1 -$416K
2 -$56.4K
3 -$23K
4
Jane Street
Jane Street
New York
-$19K
5
BlackRock
BlackRock
New York
-$6.25K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$389K
2
$271K
3
$165K
4
$55K
5
$50K
6
$40K
7
$29K
8
$27K
9
$19K
10
$17K
11
$6K
12
$6K
13
$3K
14
$1K
15
$1K
16
17
18
19